SEI Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-57,566
Closed -$2.94M – 2863
2024
Q4
$2.94M Buy
57,566
+727
+1% +$35.7K ﹤0.01% 1523
2024
Q3
$2.34M Buy
56,839
+885
+2% +$42.5K ﹤0.01% 1614
2024
Q2
$2.69M Buy
+55,954
New +$2.48M ﹤0.01% 1517
2024
Q1
– Sell
-97,131
Closed -$6.31M – 2714
2023
Q4
$6.31M Sell
97,131
-44,161
-31% -$2.66M 0.01% 1078
2023
Q3
$9.24M Buy
141,292
+10,670
+8% +$671K 0.02% 894
2023
Q2
$7.59M Sell
130,622
-18,808
-13% -$1.19M 0.01% 1002
2023
Q1
$9.23M Buy
+149,430
New +$8.97M 0.02% 890
2022
Q4
– Sell
-214,294
Closed -$15.6M – 2702
2022
Q3
$15.6M Buy
214,294
+28,817
+16% +$2.15M 0.03% 563
2022
Q2
$12.6M Buy
+185,477
New +$13.3M 0.03% 667
2021
Q3
– Sell
-5,455
Closed -$509K – 2646
2021
Q2
$509K Buy
5,455
+1,015
+23% +$98.4K ﹤0.01% 2088
2021
Q1
$475K Buy
+4,440
New +$461K ﹤0.01% 2054
2020
Q4
– Sell
-6,894
Closed -$476K – 2548
2020
Q3
$476K Buy
+6,894
New +$443K ﹤0.01% 1908

Other funds holding NARI

SEI Investments's NARI Position: Q1 2025 in Review

SEI Investments sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 57,566 shares — an estimated $2.94M sold.

SEI Investments first reported a position in NARI in Q3 2020 and held it in 12 quarters. The position peaked at $15.6M in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • SEI Investments reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SEI Investments sold 57,566 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.94M.
  • SEI Investments first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • SEI Investments's Inari Medical, Inc. Common Stock position peaked at $15.6M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on SEI Investments's 13F filing for Q1 2025, filed 13 May 2025.